FRONTIER CAPITAL MANAGEMENT CO LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$6,510,000
-85.2%
226,679
-62.8%
0.07%
-77.5%
Q4 2019$43,945,000
+7993.0%
608,741
+15613.5%
0.32%
+8025.0%
Q3 2019$543,000
-98.9%
3,874
-98.5%
0.00%
-98.9%
Q2 2019$47,736,000
+15.9%
260,725
+0.7%
0.36%
+22.9%
Q1 2019$41,174,000
+957.6%
258,877
+372.6%
0.29%
+910.3%
Q1 2017$3,893,000
-3.0%
54,781
-30.3%
0.03%
-6.5%
Q4 2016$4,015,000
-61.9%
78,641
-65.7%
0.03%
-63.1%
Q3 2016$10,543,000228,9540.08%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders